Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Urological Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Urological Cancer Drugsmarket, defines the market attractiveness level of Urological Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Urological Cancer Drugs industry, describes the types of Urological Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Urological Cancer Drugs market and the development prospects and opportunities of Urological Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Urological Cancer Drugs market in Chapter 13.
By Player:
Novartis
Ferring Pharmaceuticals
Sanofi SA
AstraZeneca
Astellas
Abbott Laboratories
Indevus Pharmaceuticals Inc
Celgene Corporation
Dendreon Corporation
Bristol-Myers Squibb
Ipsen
GlaxoSmithKline
Tolmar Inc
Johnson & Johnson
Roche Healthcare
Pfizer
By Type:
Tablets
Injection
By End-User:
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Urological Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Urological Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Urological Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Urological Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Urological Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Urological Cancer Drugs Consumption (2017-2022)
-
7.2 United States Urological Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Urological Cancer Drugs Consumption (2017-2022)
-
7.4 China Urological Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Urological Cancer Drugs Consumption (2017-2022)
-
7.6 India Urological Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Urological Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Urological Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Urological Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Urological Cancer Drugs Consumption Forecast (2022-2028)
9 Global Urological Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Urological Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Urological Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Testicular Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Global Urological Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Urological Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Urological Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Testicular Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Urological Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Urological Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Urological Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Urological Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Urological Cancer Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Urological Cancer Drugs Product and Service
-
14.2 Ferring Pharmaceuticals
-
14.2.1 Ferring Pharmaceuticals Company Details
-
14.2.2 Ferring Pharmaceuticals Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ferring Pharmaceuticals Urological Cancer Drugs Product and Service
-
14.3 Sanofi SA
-
14.3.1 Sanofi SA Company Details
-
14.3.2 Sanofi SA Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi SA Urological Cancer Drugs Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Urological Cancer Drugs Product and Service
-
14.5 Astellas
-
14.5.1 Astellas Company Details
-
14.5.2 Astellas Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Astellas Urological Cancer Drugs Product and Service
-
14.6 Abbott Laboratories
-
14.6.1 Abbott Laboratories Company Details
-
14.6.2 Abbott Laboratories Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbott Laboratories Urological Cancer Drugs Product and Service
-
14.7 Indevus Pharmaceuticals Inc
-
14.7.1 Indevus Pharmaceuticals Inc Company Details
-
14.7.2 Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Indevus Pharmaceuticals Inc Urological Cancer Drugs Product and Service
-
14.8 Celgene Corporation
-
14.8.1 Celgene Corporation Company Details
-
14.8.2 Celgene Corporation Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Celgene Corporation Urological Cancer Drugs Product and Service
-
14.9 Dendreon Corporation
-
14.9.1 Dendreon Corporation Company Details
-
14.9.2 Dendreon Corporation Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Dendreon Corporation Urological Cancer Drugs Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Urological Cancer Drugs Product and Service
-
14.11 Ipsen
-
14.11.1 Ipsen Company Details
-
14.11.2 Ipsen Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Ipsen Urological Cancer Drugs Product and Service
-
14.12 GlaxoSmithKline
-
14.12.1 GlaxoSmithKline Company Details
-
14.12.2 GlaxoSmithKline Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 GlaxoSmithKline Urological Cancer Drugs Product and Service
-
14.13 Tolmar Inc
-
14.13.1 Tolmar Inc Company Details
-
14.13.2 Tolmar Inc Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Tolmar Inc Urological Cancer Drugs Product and Service
-
14.14 Johnson & Johnson
-
14.14.1 Johnson & Johnson Company Details
-
14.14.2 Johnson & Johnson Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Johnson & Johnson Urological Cancer Drugs Product and Service
-
14.15 Roche Healthcare
-
14.15.1 Roche Healthcare Company Details
-
14.15.2 Roche Healthcare Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Roche Healthcare Urological Cancer Drugs Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer Urological Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Urological Cancer Drugs
-
Figure Urological Cancer Drugs Picture
-
Table Global Urological Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urological Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urological Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Urological Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Urological Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Urological Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Urological Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Testicular Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Testicular Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Urological Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Urological Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Urological Cancer Drugs Product and Service
-
Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ferring Pharmaceuticals Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Pharmaceuticals Urological Cancer Drugs Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Urological Cancer Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Urological Cancer Drugs Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Urological Cancer Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Urological Cancer Drugs Product and Service
-
Table Indevus Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Urological Cancer Drugs Product and Service
-
Table Dendreon Corporation (Foundation Year, Company Profile and etc.)
-
Table Dendreon Corporation Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dendreon Corporation Urological Cancer Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Urological Cancer Drugs Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Urological Cancer Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Urological Cancer Drugs Product and Service
-
Table Tolmar Inc (Foundation Year, Company Profile and etc.)
-
Table Tolmar Inc Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tolmar Inc Urological Cancer Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Urological Cancer Drugs Product and Service
-
Table Roche Healthcare (Foundation Year, Company Profile and etc.)
-
Table Roche Healthcare Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Healthcare Urological Cancer Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Urological Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Urological Cancer Drugs Product and Service
-
